TCTR20240722008RecruitingPhase 4
Efficacy of a Novel Red light with Micro-needling Patch for Facial Skin Texture
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 25 Years to 55 Years (—)
- Sex
- All
Inclusion Criteria
- •1.Participants female and male with age 25 to 55 years old with modified Fitzpatrick Wrinkle Scale more than class 1
- •2.Pre-menopause female
Exclusion Criteria
- •1.Menopause
- •2.Current tobacco use
- •3.Tattoos that cover the proposed skin surface
- •4.Outdoor workers and sun exposure risk
- •5.Any skin lesions that might affect the study results such as atopic dermatitis ,herpes simplex infection, history of active or systemic infection, history of hypertrophic scar, eczema or sunburn in the area
- •6.Any history of adverse effects of polymethylmethacrylate (PMMA)
- •7.Have done Neuromodulators treatment (Botulinum toxins injections) within 6 months
- •8.Have done Filler injections in the nasolabial fold and periorbital within 1 year
- •9.Use of energy-based devices within 1 year
- •10.Have done Mesotherapy injections within 1 month
- •11.Have done Biostimulator injection within 6 months
- •12.Have done any sort of energy-based device within 1 year
- •13.Have done any sort of LASERs or skin resurface procedures within 1 months
- •14.Underlying with Photosensitivity condition including Porphyria, Lupus erythematosus, Rosacea, Solar urticaria
- •15.Underlying with bleeding diseases
- •16.Currently on Vitamin A derivatives, anticoagulants
- •17.Pregnant or on Lactation
- •18.Daily use anti-wrinkles facial cream and/or lotion
Investigators
Similar Trials
Completed
Phase 2
Efficacy of the LED red light therapy in the treatment of Temporomandibular Joint Disorders: double blind randomized controlled trialTempromandibular DisordersTemporomandibular Joint Disorders,Red Light Therapy,TMD,PainTCTR20190406002none50
Active, not recruiting
Not Applicable
Assessment of appearance after scar removal.CTRI/2017/01/007677Dr L Krishna Prasad
Recruiting
Phase 1
A study of the efficacy and safety of microneedle patch containing triamcinolone acetonide and hydrocortisone in the treatment of inflammatory acneinflammatory acneTCTR20220830003ational Research Council of Thailand10
Completed
Phase 2
Comparison of microneedling with Tranexamic acid and PRP in treatment of MelasmaIRCT20221025056287N1Ahvaz University of Medical Sciences23
Recruiting
Phase 2
Microneedling with tranexamic acid and also microneedling with vitamin C for the treatment of melasmaChloasmaIRCT20210608051516N1Ahvaz University of Medical Sciences34